Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/3/2025

Management of High SHBG and Low Semen Volume

Understanding the Clinical Context

  • High SHBG reduces bioavailable testosterone by increasing protein binding, potentially contributing to functional hypogonadism even when total testosterone appears normal, according to the European Urology guidelines 3
  • Common causes of elevated SHBG include medications such as anticonvulsants, estrogens, and thyroid hormone, as well as medical conditions like hyperthyroidism, hepatic disease, and HIV/AIDS, and lifestyle factors including aging and smoking, as stated by the European Urology guidelines 3

Initial Diagnostic Algorithm

  • The European Urology guidelines recommend palpating for bilateral vas deferens to rule out congenital bilateral absence of vas deferens (CBAVD) 3
  • Assessing testicular size and consistency is crucial, as normal-sized testes suggest obstruction, while atrophic testes indicate spermatogenic failure, according to the European Urology guidelines 3

Treatment Based on Specific Etiology

  • For ejaculatory duct obstruction (EDO), transurethral resection of ejaculatory ducts (TURED) is the definitive treatment, which may restore natural fertility, as recommended by The Journal of Urology guidelines 5
  • For hypogonadotropic hypogonadism with high SHBG, treating underlying causes first, such as hyperthyroidism, hepatic disease, or discontinuing SHBG-elevating medications, is essential, according to the European Urology guidelines 3

Genetic Testing Before Proceeding with Assisted Reproduction

  • Karyotype testing is mandatory for azoospermia or severe oligospermia, and Y-chromosome microdeletion analysis is required for azoospermia or sperm concentration <1 million/mL, as stated by the European Urology guidelines 3

Critical Pitfalls to Avoid

  • The European Urology guidelines advise against routinely ordering TRUS or pelvic MRI as part of initial evaluation, reserving them for clear clinical suspicion of EDO based on specific criteria 3
  • Avoiding testosterone replacement therapy in men desiring fertility is crucial, as it suppresses spermatogenesis, according to The Journal of Urology guidelines 5